Compositions comprising polyethylene glycol in the therapy of Head and Neck Squamous Cell Carcinoma.

摘要

The invention pertains to compositions comprising polyethylene glycol (PEG) having a weight average molecular weight of 800 Da or greater, in particular PEG 3000 to 10,000, and a concentration of 30 mg/ml or greater, uop to about 670 mg/ml, for use in preventing and/or treating head and neck squamous cell carcinoma (HNSCC). Methods of preventing and/or treating HNSCC are also disclosed. The method comprises administering an effective amount of the composition containing the PEG, in particular for at least 1 to 14 days. PEG may or may not be the only active ingredient.